Showing 1 - 6 results of 6 for search 'Thais Pereira-Veiga', query time: 0.03s Refine Results
  1. 1
    Increased striatal adenosine A2A receptor levels is an early event in Parkinson’s disease-related pathology and it is potentially regulated by miR-34b

    Increased striatal adenosine A2A receptor levels is an early event in Parkinson’s disease-related pathology and it is potentially regulated by miR-34b by Izaskun Villar-Menéndez, Sílvia Porta, Sandra P. Buira, Thais Pereira-Veiga, Sara Díaz-Sánchez, José Luis Albasanz, Isidre Ferrer, Mairena Martín, Marta Barrachina

    Published 2014-09-01
    Get full text
    Article
  2. 2
    Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma

    Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma by Christine Nitschke, Benedikt Markmann, Leonie Konczalla, Jolanthe Kropidlowski, Thais Pereira-Veiga, Pasquale Scognamiglio, Martin Schönrock, Marianne Sinn, Marie Tölle, Jakob Izbicki, Klaus Pantel, Faik G. Uzunoglu, Harriet Wikman

    Published 2022-11-01
    Get full text
    Article
  3. 3
    Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes

    Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes by Clotilde Costa, Laura Muinelo-Romay, Victor Cebey-López, Thais Pereira-Veiga, Inés Martínez-Pena, Manuel Abreu, Alicia Abalo, Ramón M. Lago-Lestón, Carmen Abuín, Patricia Palacios, Juan Cueva, Roberto Piñeiro, Rafael López-López

    Published 2020-04-01
    Get full text
    Article
  4. 4
    The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients

    The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients by Francesca Reimer, Sarah Bryan, Karen Legler, Thomas Karn, Serenella Eppenberger-Castori, Jakob Matschke, Thais Pereira-Veiga, Harriet Wikman, Isabell Witzel, Volkmar Müller, Barbara Schmalfeldt, Karin Milde-Langosch, Udo Schumacher, Christine Stürken, Leticia Oliveira-Ferrer

    Published 2023-03-01
    Get full text
    Article
  5. 5
    Comparative evaluation of PD‐L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non‐small cell lung cancer patients

    Comparative evaluation of PD‐L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non‐small cell lung cancer patients by Mustafa Abdo, Yassine Belloum, David Heigener, Lutz Welker, Sönke vonWeihe, Milena Schmidt, Nadine Heuer‐Olewinski, Iris Watermann, Marlen Szewczyk, Jolanthe Kropidlowski, Thais Pereira‐Veiga, Hatice Elmas, Sven Perner, Stefan Steurer, Harriet Wikman, Klaus Pantel, Martin Reck

    Published 2023-05-01
    Get full text
    Article
  6. 6
    Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation.

    Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation. by Cristina Berastegui, Susana Gómez-Ollés, Alberto Mendoza-Valderrey, Thais Pereira-Veiga, Mario Culebras, Victor Monforte, Berta Saez, Manuel López-Meseguer, Helena Sintes-Permanyer, Victoria Ruiz de Miguel, Carlos Bravo, Judit Sacanell, María-Antonia Ramon, Laura Romero, María Deu, Antonio Román

    Published 2020-01-01
    Get full text
    Article

Search Tools: